The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. ANI Pharmaceuticals Inc’s current trading price is 5.82% away from its 52-week high, while its distance from the 52-week low is 55.20%. The stock’s price range for this period has been between $52.50 and $77.00 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.1 million for the day, a number notably higher than the average daily volume of 0.34 million over the last three months.
The present stock price for ANI Pharmaceuticals Inc (ANIP) is $81.48. In the last trading session, the stock made a considerable jump, reaching $100.0 after an opening price of $81.48. The stock briefly fell to $77.0 before ending the session at $69.01.
In terms of market performance, ANI Pharmaceuticals Inc had a fairly even.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
ANI Pharmaceuticals Inc (ANIP) has experienced a quarterly rise of 13.91% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.77B and boasts a workforce of 897 employees.
ANI Pharmaceuticals Inc: What Analysts Are Saying
As of right now, 3 analysts are rating ANI Pharmaceuticals Inc as a BUY, 4 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 65.53, with a change in price of +17.13. Similarly, ANI Pharmaceuticals Inc recorded 387,107 in trading volume during the last 100 days, posting a change of +26.62%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ANIP stands at 1.48. Similarly, the long-term debt-to-equity ratio is also 1.45.
ANIP Stock Stochastic Average
ANI Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 91.24%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 89.05%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 85.68% and 74.72%, respectively.
ANIP Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price gain of 28.74% this year. Over the last six months, there has been a weaker performance of 35.37%. The price of ANIP fallen by 23.27% during the last 30 days period. For the last 5-days stocks have improved 27.45%.
